3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Colorectal Neoplasms
5
Prostatic Neoplasms
2
Venous Thromboembolism
1
Thrombocythemia, Essential
1
Smoking Cessation
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Ovarian Neoplasms
1
Neoplasms
1
Motor Activity
1
Lung Neoplasms
1
Liver Cirrhosis
1
Leukemia, Hairy Cell
1
Inflammation
1
Hemorrhage
1
Fibrosis
1
Fallopian Tube Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colorectal Neoplasia
1
Carcinoma
1
Breast Neoplasms
1
Barrett Esophagus
1
Adenocarcinoma Of Esophagus
1
Interventions
apixaban
3
edoxaban
1
abelacimab
1
Rosuvastatin Calcium
1
Rivaroxaban
1
N(4)-oleylcytosine arabinoside
1
MAA868
1
Heparin, Low-Molecular-Weight
1
Dalteparin
1
Dabigatran
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Venous Thromboembolism
×
Aspirin
×
90 days
×
Clear all
NCT05198960
2026-03-20
AVAJAK
University Hospital, Brest
Phase 3
Recruiting
1,308 enrolled